2018 Disruptor 50: No. 46 Auris Health By: CNBC.com News May 22, 2018 at 06:00 AM EDT Auris received FDA approval in March for its Monarch Platform, which uses more flexible robotics during endoscopic procedures, to accurately diagnose lung cancer. Read More >>